Literature DB >> 22358337

A comparative evaluation of the small leucine-rich proteoglycans of pathological human intervertebral discs.

Sharon Brown1, James Melrose, Bruce Caterson, Peter Roughley, Stephen M Eisenstein, Sally Roberts.   

Abstract

PURPOSE: Proteoglycans are important to the functioning of the intervertebral disc. In addition to aggrecan there are the small leucine-rich proteoglycans (SLRPs). These are less common but in other locations their functions include collagen organisation, sequestering growth factors and stimulating inflammation. We have performed a comparative analysis of the SLRP core protein species present in intervertebral discs with various pathologies.
METHODS: Eighteen intervertebral discs from patients with scoliosis (n = 7, 19-53 years), degenerative disc disease (n = 6, 35-51 years) and herniations (n = 5, 33-58 years) were used in this study. Proteoglycans were dissociatively extracted from disc tissues and the SLRPs (biglycan, decorin, fibromodulin, keratocan and lumican) assessed by Western blotting following deglycosylation with chondroitinase ABC and keratanase.
RESULTS: Intact SLRP core proteins and a number of core protein fragments were identified in most of the discs examined. Biglycan and fibromodulin were the most extensively fragmented. Keratocan generally occurred as two bands, one representing the intact core protein, the other a smaller fragment. The intact core protein of lumican was detected in all samples with fragmentation evident in only one of the older scoliotic discs. Decorin was less obvious in the disc samples and showed little fragmentation.
CONCLUSION: In this cohort of pathological intervertebral discs, fragmentation of certain SLRP core proteins was common, indicating that some SLRPs are extensively processed during the pathological process. Identification of specific SLRP fragments which correlate with disc pathology may not only help understand their aetiopathogeneses, but also provide biomarkers which can be used to monitor disease progression or to identify particular disc disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22358337      PMCID: PMC3326086          DOI: 10.1007/s00586-012-2179-1

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  34 in total

1.  Catabolism of aggrecan, decorin and biglycan in tendon.

Authors:  S G Rees; C R Flannery; C B Little; C E Hughes; B Caterson; C M Dent
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration.

Authors:  Gabriella Cs-Szabo; Deborah Ragasa-San Juan; Vani Turumella; Koichi Masuda; Eugene J-M A Thonar; Howard S An
Journal:  Spine (Phila Pa 1976)       Date:  2002-10-15       Impact factor: 3.468

3.  Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon.

Authors:  Tom Samiric; Mirna Z Ilic; Christopher J Handley
Journal:  Matrix Biol       Date:  2004-05       Impact factor: 11.583

4.  Large aggregating and small leucine-rich proteoglycans are degraded by different pathways and at different rates in tendon.

Authors:  Tom Samiric; Mirna Z Ilic; Christopher J Handley
Journal:  Eur J Biochem       Date:  2004-09

5.  Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc.

Authors:  J P Thompson; R H Pearce; M T Schechter; M E Adams; I K Tsang; P B Bishop
Journal:  Spine (Phila Pa 1976)       Date:  1990-05       Impact factor: 3.468

6.  Swelling pressure of the inervertebral disc: influence of proteoglycan and collagen contents.

Authors:  J P Urban; J F McMullin
Journal:  Biorheology       Date:  1985       Impact factor: 1.875

7.  The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.

Authors:  Kristin Moreth; Rebekka Brodbeck; Andrea Babelova; Norbert Gretz; Tilmann Spieker; Jinyang Zeng-Brouwers; Josef Pfeilschifter; Marian F Young; Roland M Schaefer; Liliana Schaefer
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

8.  Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13.

Authors:  Terrence F Heathfield; Patrik Onnerfjord; Leif Dahlberg; Dick Heinegård
Journal:  J Biol Chem       Date:  2003-12-03       Impact factor: 5.157

9.  Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues.

Authors:  A R Poole; C Webber; I Pidoux; H Choi; L C Rosenberg
Journal:  J Histochem Cytochem       Date:  1986-05       Impact factor: 2.479

Review 10.  Degeneration of the intervertebral disc.

Authors:  Jill P G Urban; Sally Roberts
Journal:  Arthritis Res Ther       Date:  2003-03-11       Impact factor: 5.156

View more
  26 in total

Review 1.  Biochemical composition and turnover of the extracellular matrix of the normal and degenerate intervertebral disc.

Authors:  Sarit Sara Sivan; Anthony J Hayes; Ellen Wachtel; Bruce Caterson; Yulia Merkher; Alice Maroudas; Sharon Brown; Sally Roberts
Journal:  Eur Spine J       Date:  2013-04-17       Impact factor: 3.134

2.  The adolescent idiopathic scoliotic IVD displays advanced aggrecanolysis and a glycosaminoglycan composition similar to that of aged human and ovine IVDs.

Authors:  Cindy C Shu; James Melrose
Journal:  Eur Spine J       Date:  2018-02-13       Impact factor: 3.134

3.  Morphological changes in the human cervical intervertebral disc post trauma: response to fracture-type and degeneration grade over time.

Authors:  Ingrid Sitte; Miranda Klosterhuber; Richard Andreas Lindtner; Martin Cornelius Freund; Sabrina Barbara Neururer; Kristian Pfaller; Anton Kathrein
Journal:  Eur Spine J       Date:  2015-07-19       Impact factor: 3.134

4.  Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.

Authors:  Lachlan J Smith; Guilherme Baldo; Susan Wu; Yuli Liu; Michael P Whyte; Roberto Giugliani; Dawn M Elliott; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2012-03-30       Impact factor: 4.797

Review 5.  Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.

Authors:  Z I Johnson; Z R Schoepflin; H Choi; I M Shapiro; M V Risbud
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

6.  Decorin inhibits the proliferation of HepG2 cells by elevating the expression of transforming growth factor-β receptor II.

Authors:  Yanfeng Liu; Xuesong Wang; Zhaohui Wang; Wenbo Ju; Dawei Wang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

7.  Chondroadherin fragmentation mediated by the protease HTRA1 distinguishes human intervertebral disc degeneration from normal aging.

Authors:  Bashar Akhatib; Patrik Onnerfjord; Rahul Gawri; Jean Ouellet; Peter Jarzem; Dick Heinegård; John Mort; Peter Roughley; Lisbet Haglund
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

8.  The cellular and molecular biology of the intervertebral disc: A clinician's primer.

Authors:  W Mark Erwin; Katherine E Hood
Journal:  J Can Chiropr Assoc       Date:  2014-09

9.  Inflammatory, Structural, and Pain Biochemical Biomarkers May Reflect Radiographic Disc Space Narrowing: The Johnston County Osteoarthritis Project.

Authors:  Adam P Goode; Todd A Schwartz; Virginia B Kraus; Janet L Huebner; Steven Z George; Rebecca J Cleveland; Richard Gracely; Maria Jimenez; Louis E DeFrate; Jun Chen; Yvonne M Golightly; Joanne M Jordan
Journal:  J Orthop Res       Date:  2019-12-04       Impact factor: 3.494

Review 10.  Intervertebral Disk Degeneration: The Microenvironment and Tissue Engineering Strategies.

Authors:  Yiming Dou; Xun Sun; Xinlong Ma; Xin Zhao; Qiang Yang
Journal:  Front Bioeng Biotechnol       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.